The evidence that serotonin can communicate with and modulate Kir4.1 activity adds further complexity to the bulk of pathomechanisms, underlying depression, where Kir4.1 may at the same time be an upstream and downstream interactor of serotonergic metabolites. This evidence concerns the gene KCNJ10 and depressive symptom measurement.